All < Article List

Genome & Company shifts business strategy from microbiome to ADCs
Bio Hong Sook 06.24 11:34
OliX secures $7.3 million profit from convertible bond resale to US hedge fund
Pharma Lee Han-soo 06.24 11:31
Can President Lee deliver on his promise of reimbursed caregiving?
Policy Kwak Sung-sun 06.24 11:28
HLB’s eye drop rival to Dompé’s Oxervate misses mark in EU phase 3
Bio Kim Ji-hye 06.24 10:37
Coreline Soft expands US academic presence with AI software deal at Baylor College of Medicine
Device/ICT Lee Han-soo 06.24 10:17
CHA Vaccine’s hepatitis B shot triggers T cell response but misses primary endpoint in phase 2b
Bio Kim Ji-hye 06.24 10:14
Ybrain’s drug-free depression device tops 180K prescriptions in Korea
Device/ICT Kim Ji-hye 06.23 17:35
CHA Biotech's TIL cell therapy CHATIL selected for KDDF support project
Bio Hong Sook 06.23 16:46
[BIO USA 2025] Alteogen poised to become global SC formulation leader as MSD-led patent battles clear path
Bio Lee Han-soo 06.23 16:43
Korea doubles medical device trials, but few undergo patient testing
Device/ICT Kim Ji-hye 06.23 16:41
Bayer's Nubeqa approved in combo with androgen-blocking agent for prostate cancer
Pharma Hong Sook 06.23 15:53
Atrial fibrillation prevalence doubles in 10 years
Hospital Kim Yun-mi 06.23 15:38
Dong-A ST, Hanmi Pharm showcase obesity, MASH drug candidates at ADA 2025
Pharma Lee Han-soo 06.23 15:28
Korea falling behind in introducing new epilepsy drugs, experts warn
Hospital Kim Kyoung-Won 06.23 15:24
Korean Cancer Association to expand role as policy-clinical-public health bridge
Hospital Kim Yun-mi 06.23 13:13
Why CEO Lee is pivoting Bridge Biotherapeutics toward digital assets
Bio Hong Sook 06.23 11:40
Doctors urge Lee administration to resolve medical crisis, restore training programs
Policy Koh Jung Min 06.23 11:04
BTS Suga helps fund Korea's largest artist-backed autism center at Severance
Hospital Lee Han-soo 06.23 09:34
[BIO USA 2025] Dong-A ST unveils next-gen oncology/immunology pipeline, expands global outreach
Bio Lee Han-soo 06.23 09:26
[BIO USA 2025] SK biopharmaceuticals CEO highlights physician engagement, epilepsy sales in US
Bio Lee Han-soo 06.22 17:00

상단영역

본문영역

All articles 목록 ( 총 : 21,030 )

기사목록 보기 형태

Genome & Company shifts business strategy from microbiome to ADCs

OliX secures $7.3 million profit from convertible bond resale to US hedge fund

Can President Lee deliver on his promise of reimbursed caregiving?

HLB’s eye drop rival to Dompé’s Oxervate misses mark in EU phase 3

Coreline Soft expands US academic presence with AI software deal at Baylor College of Medicine

CHA Vaccine’s hepatitis B shot triggers T cell response but misses primary endpoint in phase 2b

Ybrain’s drug-free depression device tops 180K prescriptions in Korea

CHA Biotech's TIL cell therapy CHATIL selected for KDDF support project

[BIO USA 2025] Alteogen poised to become global SC formulation leader as MSD-led patent battles clear path

Korea doubles medical device trials, but few undergo patient testing

Bayer's Nubeqa approved in combo with androgen-blocking agent for prostate cancer

Atrial fibrillation prevalence doubles in 10 years

Dong-A ST, Hanmi Pharm showcase obesity, MASH drug candidates at ADA 2025

Korea falling behind in introducing new epilepsy drugs, experts warn

Korean Cancer Association to expand role as policy-clinical-public health bridge

Why CEO Lee is pivoting Bridge Biotherapeutics toward digital assets

Doctors urge Lee administration to resolve medical crisis, restore training programs

BTS Suga helps fund Korea's largest artist-backed autism center at Severance

[BIO USA 2025] Dong-A ST unveils next-gen oncology/immunology pipeline, expands global outreach

[BIO USA 2025] SK biopharmaceuticals CEO highlights physician engagement, epilepsy sales in US